Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 64

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 64
---
 each issued and outstanding share of Profusa preferred stock, par value $0.01, shall be converted into a number of shares of Profusa common stock, par value $0.01 (“New Profusa Common Stock”). At the Effective Time of the Merger, (i) each issued and outstanding share of Profusa Common Stock shall be converted into a number of shares of New Profusa Common Stock, based on the Exchange Ratio described below, (ii) each option to purchase Profusa Common Stock shall be converted into an option to purchase New Profusa Common Stock at the Exchange Ratio, and (iii) each warrant to purchase Profusa Common Stock shall be converted into a warrant to purchase New Profusa Common Stock at the Warrant Ratio (as defined in the Merger Agreement). The Exchange Ratio will be equal to the value of a share of Profusa Common Stock, based on the sum of (a) an equity valuation of Profusa of $155,000,000 and (b) the Incentive Equity Value (which is expected to be $29,018,330 for purposes of this proxy statement/prospectus), plus (c) the Private Placement Value (which is expected to be $14,867,899 for purposes of this proxy statement/prospectus), plus (d) the Aggregate Exercise Price, minus (e) the Aggregate Company Incentive Amount, divided by an assumed value of New Profusa Common Stock of $10.00 per share. As of [ ], the Exchange Ratio and the Per Share Merger Consideration are estimated to be [ ] and [ ], respectively, at the time of Closing. Subject to certain future revenue and stock -pricebased milestones, Profusa shareholders will have the right to receive an aggregate of up to an additional 3,875,000shares of New Profusa Common Stock (the “Earnout Shares”). One -quarterof the Earnout Shares will be issued if, either (i) between the 18 -monthanniversary and the two -yearanniversary of the Closing, the combined company’s common stock achieves a closing sale price of at least $12.50 per share for any 20 trading days within a 30 consecutive trading day period or (ii) the consummation 3 of a subsequent transaction occurs during this period, pursuant to which the combined company’s stockholders receive the right to consideration implying a per share value of the combined company’s common stock of at least $12.50 (“Milestone Event I”). One -quarterof the